Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia.

Bibliographic Details
Title:	Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia.
Authors:	Kantarjian, Hagop M., Thomas, Xavier G., Dmoszynska, Anna, Wierzbowska, Agnieszka, Mazur, Grzegorz, Mayer, Jiri, Jyh-Pyng Gau, Wen-Chien Chou, Buckstein, Rena, Cermak, Jaroslav, Ching-Yuan Kuo, Oriol, Albert, Ravandi, Farhad, Faderl, Stefan, Delaunay, Jacques, Lysák, Daniel, Minden, Mark, Arthur, Christopher
Source:	Journal of Clinical Oncology; 7/20/2012, Vol. 30 Issue 21, p2670-2677, 8p
Database:	Supplemental Index

More Details
ISSN:	0732183X
DOI:	10.1200/JCO.2011.38.9429
Published in:	Journal of Clinical Oncology
Language:	English